Breast self-examination and death from breast cancer: a meta-analysis

被引:117
作者
Hackshaw, AK [1 ]
Paul, EA [1 ]
机构
[1] Univ London, Barts & London Sch Med & Dent, Wolfson Inst Environm & Prevent Med, Queen Mary, London EC1M 6BQ, England
关键词
breast self-examination; breast cancer; mortality; meta-analysis;
D O I
10.1038/sj.bjc.6600847
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Breast self-examination (BSE) is widely recommended for breast cancer prevention. Following recent controversy over the efficacy of mammography, it may be seen as an alternative. We present a meta-analysis of the effect of regular BSE on breast cancer mortality. From a search of the medical literature, 20 observational studies and three clinical trials were identified that reported on breast cancer death rates or rates of advanced breast cancer (a marker of death) according to BSE practice. A lower risk of mortality or advanced breast cancer was only found in studies of women with breast cancer who reported practising BSE before diagnosis (mortality: pooled relative risk 0.64, 95% Cl 036-0.73; advanced cancer, pooled relative risk 0.60, 95% Cl 0.46-0.80). The results are probably due to bias and confounding. There was no difference in death rate in studies on women who detected their cancer during an examination (pooled relative risk 0.90, 95% Cl 0.72-1.12). None of the trials of BSE training (in which most women reported practising it regularly) showed lower mortality in the BSE group (pooled relative risk 1.0 1, 95% Cl 0.92-1.12). They did show that BSE is associated with considerably more women seeking medical advice and having biopsies, Regular BSE is not an effective method of reducing breast cancer mortality.
引用
收藏
页码:1047 / 1053
页数:7
相关论文
共 43 条
[1]  
[Anonymous], BREAST
[2]   Breast self-examination and survival from breast cancer - A prospective follow-up study [J].
Auvinen, A ;
Elovainio, L ;
Hakama, M .
BREAST CANCER RESEARCH AND TREATMENT, 1996, 38 (02) :161-168
[3]   EUROPEAN-SCHOOL-OF-ONCOLOGY ADVISORY REPORT TO THE EUROPEAN-COMMISSION FOR THE EUROPE AGAINST CANCER PROGRAM EUROPEAN-CODE-AGAINST-CANCER [J].
BOYLE, P ;
VERONESI, J ;
TUBIANA, M ;
ALEXANDER, FE ;
DASILVA, FC ;
DENIS, LJ ;
FREIRE, JM ;
HAKAMA, M ;
HIRSCH, A ;
KROES, R ;
LAVECCHIA, C ;
MAISONNEUVE, P ;
MARTINMORENO, JM ;
NEWTONBISHOP, J ;
PINDBORG, JJ ;
SARACCI, R ;
SCULLY, C ;
STANDAERT, B ;
STORM, H ;
BIANCO, S ;
MALBOIS, R ;
BLEEHEN, N ;
DICATO, M ;
PLESNICAR, S .
EUROPEAN JOURNAL OF CANCER, 1995, 31A (09) :1395-1405
[4]   METAANALYSIS IN CLINICAL-TRIALS [J].
DERSIMONIAN, R ;
LAIRD, N .
CONTROLLED CLINICAL TRIALS, 1986, 7 (03) :177-188
[5]  
FELDMAN JG, 1981, CANCER, V47, P2740, DOI 10.1002/1097-0142(19810601)47:11<2740::AID-CNCR2820471133>3.0.CO
[6]  
2-4
[7]  
FOSTER RS, 1984, CANCER, V53, P999, DOI 10.1002/1097-0142(19840215)53:4<999::AID-CNCR2820530429>3.0.CO
[8]  
2-N
[9]  
GASTRIN G, 1994, CANCER, V73, P2168, DOI 10.1002/1097-0142(19940415)73:8<2168::AID-CNCR2820730822>3.0.CO
[10]  
2-V